| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 6.549 | 7.540 | 7.007 | 23.640 | 17.526 | 27.503 | 26.523 | 26.692 | 22.060 |
| Total Income - EUR | - | 6.549 | 7.540 | 7.007 | 23.652 | 17.526 | 27.503 | 26.523 | 26.692 | 22.060 |
| Total Expenses - EUR | - | 1.624 | 2.455 | 2.793 | 3.617 | 2.901 | 2.681 | 3.236 | 3.824 | 4.006 |
| Gross Profit/Loss - EUR | - | 4.926 | 5.085 | 4.214 | 20.035 | 14.625 | 24.822 | 23.287 | 22.867 | 18.054 |
| Net Profit/Loss - EUR | - | 4.752 | 4.859 | 4.003 | 19.325 | 14.137 | 23.997 | 22.507 | 19.265 | 15.168 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Corivas Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 19 | 651 | 815 | 285 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 6.120 | 10.851 | 12.773 | 32.590 | 14.543 | 24.591 | 23.871 | 20.126 | 31.160 |
| Inventories | - | 0 | 0 | 149 | 0 | 0 | 99 | 109 | 0 | 0 |
| Receivables | - | 3.439 | 2.023 | 1.927 | 1.986 | 2.122 | 17.076 | 22.046 | 4.841 | 19.397 |
| Cash | - | 2.681 | 8.828 | 10.697 | 30.604 | 12.421 | 7.417 | 1.717 | 15.285 | 11.763 |
| Shareholders Funds | - | 4.797 | 9.575 | 13.402 | 32.468 | 14.186 | 24.046 | 22.556 | 19.312 | 15.217 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.342 | 1.928 | 186 | 407 | 357 | 546 | 1.315 | 814 | 15.943 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Corivas Med Srl